| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |